SCHEMBL19207570

SCHEMBL19207570

O=CCC1(c2ccccc2)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.54
MAOB P27338 1/20 0.54
TAAR1 Q96RJ0 1/20 0.54
DPP4 P27487 2/20 0.45
OPRM1 P35372 1/20 0.42
OPRL1 P41146 1/20 0.42
SLC6A4 P31645 2/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A3 Q01959 1/20 0.40
LMNA P02545 2/20 0.39
CNR1 P21554 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MEN1 O00255 1/20 0.38
CYP2C9 P11712 1/20 0.38
KMT2A Q03164 1/20 0.38
TSHR P16473 2/20 0.37
HTT P42858 1/20 0.37
AKR1C1 Q04828 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16515961 0.92 DPP4 (0.52) MAOAMAOBTAAR1DPP4SLC6A4
SCHEMBL8107358 0.92 DPP4 (0.57) MAOAMAOBTAAR1DPP4SLC6A4
SCHEMBL432476 0.90 DPP4 (0.55) MAOAMAOBTAAR1DPP4SLC6A4
SCHEMBL38042 0.87 TACR1 (0.51) MAOAMAOBTAAR1OPRM1SLC6A4
SCHEMBL31147375 0.86 MAOA (0.42) MAOAMAOBTAAR1DPP4OPRM1
SCHEMBL3527130 0.81 HSD11B1 (0.42) MAOAMAOBTAAR1OPRM1LMNA
SCHEMBL3406637 0.79 SLC6A4 (0.47) MAOAMAOBSLC6A4SLC6A2SLC6A3
SCHEMBL4775989 0.79 MAOA (0.39) MAOAMAOBTAAR1DPP4OPRM1
SCHEMBL3523461 0.78 CCR5 (0.51) LMNA
SCHEMBL13211397 0.77 SLC6A4 (0.46) DPP4OPRM1SLC6A4SLC6A2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109071504-A Inhibitors of receptor interacting protein kinase 1 戴纳立制药公司 2018-12-21 CN disclosed
EP-3414239-A2 INHIBITORS OF RECEPTOR-INTERACTING PROTEIN KINASE 1 Denali Therapeutics Inc. (US) 2018-12-19 EP disclosed
WO-2017136727-A2 COMPOUNDS, COMPOSITIONS AND METHODS DENALI THERAPEUTICS INC. (US) 2017-08-10 WO disclosed